These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24684362)

  • 1. Reply from the authors.
    Querejeta Roca G; Redline S; Punjabi N; Claggett B; Ballantyne CM; Solomon SD; Shah AM
    Am J Respir Crit Care Med; 2014 Apr; 189(7):869-70. PubMed ID: 24684362
    [No Abstract]   [Full Text] [Related]  

  • 2. The association between obstructive sleep apnea severity and N-terminal pro-B-type natriuretic peptide levels in women.
    Lin GM
    Am J Respir Crit Care Med; 2014 Apr; 189(7):869. PubMed ID: 24684363
    [No Abstract]   [Full Text] [Related]  

  • 3. Sleep apnea and subclinical myocardial injury: where do we stand?
    Olafiranye O; Reis S; Strollo PJ
    Am J Respir Crit Care Med; 2013 Dec; 188(12):1394-5. PubMed ID: 24328773
    [No Abstract]   [Full Text] [Related]  

  • 4. Obstructive sleep apnea and preclinical cardiac damage: need for U.S. representative study sample.
    Mirrakhimov AE
    Am J Respir Crit Care Med; 2014 Apr; 189(7):868-9. PubMed ID: 24684361
    [No Abstract]   [Full Text] [Related]  

  • 5. Sleep apnea is associated with subclinical myocardial injury in the community. The ARIC-SHHS study.
    Querejeta Roca G; Redline S; Punjabi N; Claggett B; Ballantyne CM; Solomon SD; Shah AM
    Am J Respir Crit Care Med; 2013 Dec; 188(12):1460-5. PubMed ID: 24156237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker Screening for Viable Myocardium in Ischemic Cardiomyopathy: Interesting… If Viability Is Important.
    Strauss BH; Roifman I
    Can J Cardiol; 2017 Nov; 33(11):1457-1458. PubMed ID: 28966020
    [No Abstract]   [Full Text] [Related]  

  • 7. Markers of Myocardial Ischemia in Patients with Obstructive Sleep Apnea and Coronary Artery Disease.
    Valo M; Wons A; Moeller A; Teupe C
    Pulm Med; 2015; 2015():621450. PubMed ID: 26090222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of Mayo Clinic Staging System for Light Chain Amyloidosis With High-Sensitivity Troponin.
    Kumar SK; Gertz MA; Dispenzieri A
    J Clin Oncol; 2019 Jan; 37(2):171-173. PubMed ID: 30433848
    [No Abstract]   [Full Text] [Related]  

  • 9. The relationship between two laboratory assays: High sensitivity troponin T and N-terminal pro-brain natriuretic peptide.
    Kaur N; Singletary A; Engineer R; Nowacki AS; Fertel BS; Smalley CM
    Am J Emerg Med; 2020 Dec; 38(12):2750-2751. PubMed ID: 32409102
    [No Abstract]   [Full Text] [Related]  

  • 10. Markers of Myocardial Ischemia in Patients With Coronary Artery Disease and Obstructive Sleep Apnea: Effect of Continuous Positive Airway Pressure Therapy.
    Valo M; Wons A; Moeller A; Teupe C
    Clin Cardiol; 2015 Aug; 38(8):462-8. PubMed ID: 26175232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers and atrial fibrillation: is it prime time yet?
    Mahajan R; Lau DH; Sanders P
    Heart; 2014 Aug; 100(15):1151-2. PubMed ID: 24846972
    [No Abstract]   [Full Text] [Related]  

  • 12. Can we save the kidneys by protecting the heart?
    Chirakarnjanakorn S; Tang WH
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):165-6. PubMed ID: 25605699
    [No Abstract]   [Full Text] [Related]  

  • 13. Directions from Hecate: towards a multi-marker approach for heart failure assessment.
    Kakkar R; Lee RT
    Eur J Heart Fail; 2011 Jul; 13(7):691-3. PubMed ID: 21712290
    [No Abstract]   [Full Text] [Related]  

  • 14. Disparate worlds drawing closer together: cardiovascular biomarkers predict cancer outcomes in treatment-naïve patients.
    Lyon AR
    Heart; 2015 Dec; 101(23):1853-4. PubMed ID: 26416835
    [No Abstract]   [Full Text] [Related]  

  • 15. Comment on Hillis et al. The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic Peptide to predict cardiovascular events and death in patients with type 2 diabetes. Diabetes care 2014;37:295-303.
    Neuhold S; Pacher R; Hülsmann M
    Diabetes Care; 2014 Jun; 37(6):e152-3. PubMed ID: 24855180
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to comment on Hillis et al. The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic Peptide to predict cardiovascular events and death in patients with type 2 diabetes. Diabetes care 2014;37:295-303.
    Hillis GS; Welsh P; Chalmers J; Woodward M; Sattar N
    Diabetes Care; 2014 Jun; 37(6):e154. PubMed ID: 24855181
    [No Abstract]   [Full Text] [Related]  

  • 17. N-terminal pro-B-type naturetic peptide (NTBNP): so much promise and such a disappointment.
    Cherniack NS
    Sleep Breath; 2008 Mar; 12(1):3-5. PubMed ID: 17906884
    [No Abstract]   [Full Text] [Related]  

  • 18. Obstructive sleep apnea: effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers, echocardiography, and cardiac MRI.
    Colish J; Walker JR; Elmayergi N; Almutairi S; Alharbi F; Lytwyn M; Francis A; Bohonis S; Zeglinski M; Kirkpatrick IDC; Sharma S; Jassal DS
    Chest; 2012 Mar; 141(3):674-681. PubMed ID: 21835901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac biomarkers and prediction of ESRD.
    Nicholas SB
    Am J Kidney Dis; 2011 Nov; 58(5):689-91. PubMed ID: 22014633
    [No Abstract]   [Full Text] [Related]  

  • 20. Reference ranges for cardiac troponin in the era of high sensitivity assays.
    Collinson P
    Clin Biochem; 2013 Nov; 46(16-17):1629-30. PubMed ID: 24160455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.